click below
click below
Normal Size Small Size show me how
CV 3
| Pharmacologic Category | Generic | Brand | Classification | Indication | Key Side effect | US Boxed Warning | Other Notes |
|---|---|---|---|---|---|---|---|
| Anticoagulant, direct thrombin inhibitor | dabigatran (PO) | Pradaxa | n/a | AF (stroke prevention), VTE | bleeding, dyspepsia | premature discontinuation increases risk of thrombotic events; increased risk of epidural or spinal hematoma in patient undergoing spinal puncture | swallow whole; dispense and store in original packaging; discard 4 months after opening |
| Anticoagulant, factor Xa inhibitor | apixaban (PO) | Eliquis | n/a | AF (stroke prevention), VTE | bleeding | premature discontinuation increases risk of thrombotic events; increased risk of epidural or spinal hematoma in patient undergoing spinal puncture | n/a |
| Anticoagulant, factor Xa inhibitor | rivaroxaban (PO) | Xarelto | n/a | AF (stroke prevention), VTE, PAD | bleeding | premature discontinuation increases risk of thrombotic events; increased risk of epidural or spinal hematoma in patient undergoing spinal puncture | n/a |
| Anticoagulant, vitamin K antagonist | warfarin (PO) | Coumadin, Jantoven | n/a | AF (stroke prevention), VTE | bleeding, skin necrosis | bleeding risk | narrow therapeutic index drug (toxicity may occur at concentrations close to therapeutic range; therapeutic monitoring recommended with INR). dose dependent tablet colors; consistent vitamin K intake recommended; many drug interactions |
| Anticoagulant, low molecular weight heparin | enoxaparin (SQ) | Lovenox | n/a | ACS, VTE | bleeding, HIT | increased risk of epidural or spinal hematoma in patients undergoing spinal puncture | do not expel air bubble from syringe prior to injection |
| Anticoagulant | heparin (IV, SQ) | n/a | n/a | ACS, VTE | bleeding, hyperkalemia (chronic use), HIT | n/a | n/a |
| Antiplatelet agent | clopidogrel (PO) | Plavix | n/a | CAD, stroke | bleeding | diminished effectiveness in poor metabolizers | n/a |
| Antiplatelet agent | ticagrelor (PO) | Brilinta | n/a | ACS | bleeding, dyspnea | significant, sometimes fatal bleeding; do not exceed aspirin >100 mg daily due to reduced ticagrelor effectiveness | n/a |
| Antiplatelet agent | aspirin (PO) | Bayer, Bufferin, Ecotrin | OTC | ACS, stable angina, pain, stroke | dyspepsia, heartburn, bleeding | n/a | CI in NSAID or salicylate allergy, children and teenagers with viral infection (due to Reye’s syndrome), can cause tinnitus in salicylate overdose |
| Vasodilator | nitroglycerin (SL) | Nitrostat | n/a | ACS, stable angina | headache, flushing, syncope, dizziness | n/a | do not use with PDE-5 Inhibitors; tachyphylaxis (tolerance/ ↓ effectiveness); can aggravate angina causes by hypertrophic cardiomyopathy |
| Fibrinolytic | alteplase (intracatheter, IV) | Intracatheter: Cathflo Activase, IV: Activase | n/a | Intracatheter: catheter clearance IV: STEMI, acute ischemic stroke, PE | bleeding | n/a | CI in patients with severe uncontrolled HTN |